Hizentra
Human Immunoglobulin G · Liquid · Subcutaneous
No FDA structured label text is available for Hizentra. The NDC listings below come from the FDA National Drug Code directory.
Active ingredients
- Human Immunoglobulin G in 7 products
Hizentra NDC products (7)
| NDC | Strength & form | Labeler | Type |
|---|---|---|---|
| 44206-451 | Human Immunoglobulin G .2 g/mL Liquid | CSL Behring AG | BLA |
| 44206-452 | Human Immunoglobulin G .2 g/mL Liquid | CSL Behring AG | BLA |
| 44206-454 | Human Immunoglobulin G .2 g/mL Liquid | CSL Behring AG | BLA |
| 44206-455 | Human Immunoglobulin G .2 g/mL Liquid | CSL Behring AG | BLA |
| 44206-456 | Human Immunoglobulin G .2 g/mL Liquid | CSL Behring AG | BLA |
| 44206-457 | Human Immunoglobulin G .2 g/mL Liquid | CSL Behring AG | BLA |
| 44206-458 | Human Immunoglobulin G .2 g/mL Liquid | CSL Behring AG | BLA |
Frequently asked questions
Who makes Hizentra?
Hizentra is listed by 1 labeler in the FDA NDC directory, including CSL Behring AG.